학술논문
Cancer Survival in Adults in Spain: A Population-Based Study of the Spanish Network of Cancer Registries (REDECAN).
Document Type
Academic Journal
Author
Guevara M; Navarra Public Health Institute, 31003 Pamplona, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain.; Navarra Institute for Health Research (IdiSNA), 31008 Pamplona, Spain.; Molinuevo A; Biodonostia Health Research Institute, 20014 San Sebastian, Spain.; Salmerón D; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain.; Departamento de Ciencias Sociosanitarias, IMIB-Arrixaca, Universidad de Murcia, 30100 Murcia, Spain.; Marcos-Gragera R; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain.; Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Catalan Institute of Oncology, Department of Health, Government of Catalonia, 17007 Girona, Spain.; Descriptive Epidemiology, Genetics and Cancer Prevention Research Group, Girona Biomedical Research Institute (IdiBGi), 17190 Girona, Spain.; Faculty of Medicine, University of Girona, 17071 Girona, Spain.; Josep Carreras Leukemia Research Institute, 17003 Girona, Spain.; Carulla M; Tarragona Cancer Registry, Cancer Epidemiology and Prevention Service, Hospital Universitari Sant Joan de Reus, CatSalut, 43204 Reus, Spain.; Pere Virgili Health Research Institute (IISPV), 43204 Reus, Spain.; Faculty of Medicine and Health Sciences, Rovira i Virgili University, 43204 Reus, Spain.; Chirlaque MD; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain.; Departamento de Ciencias Sociosanitarias, IMIB-Arrixaca, Universidad de Murcia, 30100 Murcia, Spain.; Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, 30008 Murcia, Spain.; Rodríguez Camblor M; Public Health Directorate of Asturias, 33006 Oviedo, Spain.; Alemán A; Canary Islands Cancer Registry, Public Health Directorate, Canary Health Service, 35003 Las Palmas de Gran Canaria, Spain.; Rojas D; Canary Islands Cancer Registry, Public Health Directorate, Canary Health Service, 35003 Las Palmas de Gran Canaria, Spain.; Vizcaíno Batllés A; Castellón Cancer Registry, Public Health Directorate, General Health Department, Generalitat Valenciana, 46020 Valencia, Spain.; Chico M; Ciudad Real Cancer Registry, Health and Social Welfare Authority, Castile-La Mancha, 13071 Ciudad Real, Spain.; Jiménez Chillarón R; Cuenca Cancer Registry, Health and Social Welfare Authority, Castile-La Mancha, 16071 Cuenca, Spain.; López de Munain A; Basque Country Cancer Registry, Health Department, 01010 Vitoria, Spain.; de Castro V; Basque Country Cancer Registry, Health Department, 01010 Vitoria, Spain.; Sánchez MJ; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain.; Escuela Andaluza de Salud Pública (EASP), 18011 Granada, Spain.; Instituto de Investigación Biosanitaria ibs.GRANADA, 18012 Granada, Spain.; Department of Preventive Medicine and Public Health, University of Granada, 18071 Granada, Spain.; Ramalle-Gómara E; Department of Epidemiology and Prevention, La Rioja Regional Health Authority, 26071 Logroño, Spain.; Franch P; Balearic Islands Health Research Institute (IdISBa), Illes Balears, 07120 Palma, Spain.; Mallorca Cancer Registry, Balearic Islands Public Health Department, 07010 Palma, Spain.; Galceran J; Tarragona Cancer Registry, Cancer Epidemiology and Prevention Service, Hospital Universitari Sant Joan de Reus, CatSalut, 43204 Reus, Spain.; Pere Virgili Health Research Institute (IISPV), 43204 Reus, Spain.; Faculty of Medicine and Health Sciences, Rovira i Virgili University, 43204 Reus, Spain.; Ardanaz E; Navarra Public Health Institute, 31003 Pamplona, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), 28029 Madrid, Spain.; Navarra Institute for Health Research (IdiSNA), 31008 Pamplona, Spain.
Source
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Subject
Language
English
ISSN
2072-6694
Abstract
The assessment of cancer survival at the population level is essential for monitoring progress in cancer control. We aimed to assess cancer survival and its trends in adults in Spain. Individual records of 601,250 adults with primary cancer diagnosed during 2002-2013 and followed up to 2015 were included from 13 population-based cancer registries. We estimated net survival up to five years after diagnosis and analyzed absolute changes between 2002-2007 and 2008-2013. Estimates were age-standardized. Analyses were performed for 29 cancer groups, by age and sex. Overall, age-standardized five-year net survival was higher in women (61.7%, 95% CI 61.4-62.1%) than in men (55.3%, 95% CI 55.0-55.6%), and ranged by cancer from 7.2% (pancreas) to 89.6% (prostate) in men, and from 10.0% (pancreas) to 93.1% (thyroid) in women in the last period. Survival declined with age, showing different patterns by cancer. Between both periods, age-standardized five-year net survival increased overall by 3.3% (95% CI 3.0-3.7%) in men and 2.5% (95% CI 2.0-3.0%) in women, and for most cancer groups. Improvements were greater in patients younger than 75 years than in older patients. Chronic myeloid leukemia and myeloma showed the largest increases. Among the most common malignancies, the greatest absolute increases in survival were observed for colon (5.0%, 95% CI 4.0-6.0%) and rectal cancers (4.5%, 95% CI 3.2-5.9%). Survival improved even for some cancers with poor prognosis (pancreas, esophagus, lung, liver, and brain cancer). Further investigation of possible sociodemographic inequalities is warranted. This study contributes to the evaluation of cancer control and health services' effectiveness.